Early Phase 1 Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman between the ages of 25 and 65
- You have had widespread pain throughout your body for at least 12 months
- You have been diagnosed with fibromyalgia based on the 2016 American College of Rheumatology criteria
- You are willing and able to fill in a daily report during the early part of the study (completing at least 80% of the entries)
- You are able to travel to UAB (University of Alabama at Birmingham) for all scheduled visits
- You can read and write in English
- You have never used hallucinogens, or your last use was at least 3 years ago
- You have a trusted friend or family member who can accompany you and drive you home after the medication session
- Your average daily pain level is at least 5 out of 10
- If you are currently taking any medications that are not allowed in the study, you are willing to stop them for a set period of time before the study begins (confirm with trial site for details)
Who may not be able to join:
- You are male
- You have used opioid pain medications (such as codeine or oxycodone) in the last 60 days
- You regularly take anti-inflammatory medications such as aspirin, ibuprofen, or naproxen
- You take blood-thinning medications
- You currently take certain antidepressants, mood stabilizers, antipsychotics, lithium, St. John's Wort, or other medications that affect serotonin levels (confirm with trial site for the full list)
- You drink grapefruit juice every day
- You have had a fever or taken antibiotics in the 4 weeks before the study starts
- You have had surgery recently or are planning surgery during the study period
- You are planning to move away from the Birmingham area within the next 6 months
- You have had a vaccination recently or are planning one during the study period
- You are currently taking part in another treatment trial
- You are pregnant, planning to become pregnant within 6 months, or currently breastfeeding
- You have a significant untreated or unstable mental health condition, or you scored highly on a depression screening questionnaire (confirm with trial site)
- You have a current or past history of any psychotic disorder (such as schizophrenia)
- You have a current or past history of bipolar disorder (type I or II)
- A parent, sibling, or child of yours has had a psychotic disorder or bipolar disorder
- You are currently having thoughts of harming yourself or others
- You have been diagnosed with a rheumatological or autoimmune condition (such as lupus or rheumatoid arthritis)
- You have a blood or clotting disorder
- You have high blood pressure or a resting heart rate above 90 beats per minute
- You currently have an active infection with a fever
- Certain blood test results are outside acceptable ranges, including markers of inflammation, thyroid levels, or signs of autoimmune activity (confirm with trial site)
- You are dependent on any mind-altering substances other than nicotine or caffeine
- You take the antiviral medication efavirenz
- You take certain medications used for erectile dysfunction or related conditions (confirm with trial site)
- You have severe anaemia
- You have certain health conditions including phenylketonuria, chronic bronchitis, emphysema, asthma, diabetes, liver disease, or a persistent cough with mucus or breathing difficulties
- You use any medication containing dextromethorphan (found in some cough medicines)
- Your pain is primarily caused by a condition other than fibromyalgia
- You take certain medications that affect how the body processes drugs (known as CYP2D6 inhibitors, confirm with trial site)
- Based on genetic testing, your body processes a certain enzyme (CYP2D6) more slowly than average (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 205-202-1387
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in daily self-reported pain severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.